PubMed:28854065 / 203-380
Annnotations
PubMed_ArguminSci
{"project":"PubMed_ArguminSci","denotations":[{"id":"T1","span":{"begin":0,"end":177},"obj":"DRI_Challenge"}],"text":"Purpose We examined the efficacy and safety of thalidomide (THD) for the prevention of delayed nausea and vomiting in patients who received highly emetogenic chemotherapy (HEC)."}